• Propecia Does Not Increase Prostate Cancer Risk According to Chief Medical Officer of The American Cancer Society

    The news has spread far and wide through the hair loss community that the Food and Drug Administration expanded their warning last Thursday on a group of drugs which includes finasteride (Proscar/Propecia), stating that using these drugs may increase the risk of high grade prostate cancer.

    The latest  warning indicates that 5 alpha reductase inhibitors (which include the hair loss drug Propecia) are linked to a greater risk of high grade prostate cancers. However, many physicians, including prostate cancer specialists, believe that these drugs actually improve the ability to detect aggressive tumors that already exist in patients, which can prove to be life saving.

    According to Otis Brawley, M.D., chief medical officer and executive vice president of the American Cancer Society, this latest FDA warning has been misinterpreted by many and he felt it was important to set the record straight.

    Spencer Kobren speaks with Dr. Otis Brawley of The American Cancer Society

     
  • Propecia Feared To Cause Permanent Impotence

    The hair loss community is in a panic, and our email boxes are full with correspondence from frightened hair loss sufferers from around the world.

    According to reports on a recent study originally published online in the Journal of Sexual Medicine, men who choose to take the drug finasteride to treat their hair loss are playing russian roulette with their sex lives. Some researchers, anti-Propecia blogs, and the mainstream media assert either accept hair loss or risk permanent impotence by attempting to treat it.

    According to the latest study conducted by Dr. Michael Irwig and his team at George Washington University Medical School, 92 percent of study participants reported developing erectile dysfunction after taking finasteride, with 94 percent reporting that they experienced low sexual desire, 92
    percent reporting a decline in sexual arousal and 69 percent claimed trouble achieving an orgasm.

    Well, these findings shouldn’t be too surprising especially since 100 percent of the study participants were men who reported suffering sexual dysfunction after taking the drug finasteride prior to participating in the study. Read more ›

     
  • Genes May Predict Treatment Efficacy For Women Suffering With Hair Loss

    A six month pilot study conducted by molecular dermatology and research innovator Hair DX, suggests that certain genetic mechanisms can help predict if the breakthrough hair loss drug Propecia (Finasteride), primary prescribed to men, could actually be effective in the treatment of female pattern hair loss in post menopausal women.

    “Results of our pilot study are very encouraging, as it appears we have found a key piece of the genetic puzzle which identifies women who can benefit from Finasteride therapy in the same way men do. Our findings suggest these women actually have a female corollary to male pattern hair loss (Androgenetic Alopecia), and that is an important finding,” says IAHRS Accepted Member Dr. Sharon Keene, Chief Medical Officer of HairDX. “Once these results are confirmed, it can usher in a new era of treatment for female Androgenetic Alopecia.”

    Read Full Story:

    http://www.news-medical.net/news/20100224/Study-indicates-Finasteride-therapy-may-benefit-women-suffering-from-hair-loss.aspx

     
 
 

Subscribe

Enter your email address:

 
 

"Spencer Kobren's nationally syndicated show "The Bald Truth" has a dedicated listenership that would have Rush Limbaugh pulling his hair out in envy." --Pittsburgh Tribune-Review.

 
 
 
 
 

BaldTruthTalk Forums

 
 

Talk

 
 
 
 
 
 

News